Koshikawa et al. identified a fusion gene, LAMC2‐NR6A1, producing a short form of Ln‐γ2 (Lm‐γ2F), that possessed similar bioactivity for EGFR phosphorylation to that of the EGF ligand in ovarian cancer.27 The gene discussed is LAMC2; the disease is ovarian carcinoma.